Tag Archives: drug costs

Pharmaceutical costs–what’s behind them

I have been recovering from my hip replacement surgery with a few post surgical complications from another ailment.  That said, I could not resist sharing this link from the Kaiser Family Foundation news service. They are a 501© 3 non-profit … Continue reading

Posted in consumer protection, pharmaceutical companies, prescription drugs, technology and pharmaceutical costs, Uncategorized | Tagged , , , , , , | Leave a comment

Congress Tackles Drug Prices: Much Bipartisan Support; and Recent Trends in Drug Costs Here and What Other Countries Pay

Finally it looks like Congress might just re-visit Medicare Part D and let Medicare negotiate rates with drug companies.   See charts below: http://www.statnews.com/2015/12/01/stat-harvard-drug-prices-poll/  The VA and Medicaid can negotiate rates. Senate Special Committee on Aging holds drug costs hearing December … Continue reading

Posted in aging, Economy, media, Medicare, pharmaceutical companies, policy and politics, politics, prescription drugs, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Drug Costs and Congress: Investments, Contributions and You

A scathing new article on Congress and its financial conflicts of interests with drug and device companies appears in STAT, a news firm specializing in health and science. It examines Senators and Representatives who have oversight of the FDA and … Continue reading

Posted in health insurance, medical bankruptcy, Medicare, pharmaceutical companies, policy and politics, prescription drugs, public dialogue, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Drug Clinical Trials, Comparative Effectiveness, and much more

In 2013, I ran a 2 column series on how pharmaceutical products are tested and evaluated before going on the market (see link below). In light of the current discussions about drug prices, here are some things you might be … Continue reading

Posted in business, consumer protection, pharmaceutical companies, prescription drugs | Tagged , , , , , , , , , , , , , , , , | Leave a comment

What You CAN Do About Prescription Drug Costs

What American’s Think About Prices and What You Can Do                      “Corporations now spend at least $2.6 billion a year lobbying Congress—more than the $2 billion taxpayers spend funding the House and the Senate.”  The Week, July 31, 2015 What … Continue reading

Posted in consumer protection, Economy, health insurance, medical bankruptcy, Medicare, patients' voice, policy and politics, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , | Leave a comment